In the supernatants of pancreatic cancer cells and serum from patients with pancreatic cancer, Sanger sequencing analyses of polymerase chain reaction (PCR) amplicons have identified KRAS and TP53 mutations [11]. The gene discussed is TP53; the disease is pancreatic neoplasm.